Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers

INTRODUCTION: Models characterizing intermediate disease stages of Alzheimer's disease (AD) are needed to inform clinical care and prognosis. Current models, however, use only a small subset of available biomarkers, capturing only coarse changes along the complete spectrum of disease progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Devendra, Tjandra, Donna, Migrino, Raymond Q., Giordani, Bruno, Syed, Zeeshan, Wiens, Jenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234900/
https://www.ncbi.nlm.nih.gov/pubmed/30456290
http://dx.doi.org/10.1016/j.dadm.2018.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234900/
https://www.ncbi.nlm.nih.gov/pubmed/30456290
http://dx.doi.org/10.1016/j.dadm.2018.06.007

Ejemplares similares